These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14969817)
21. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells. Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847 [TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis. Milas L Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859 [TBL] [Abstract][Full Text] [Related]
23. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. Fong LY; Zhang L; Jiang Y; Farber JL J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379 [TBL] [Abstract][Full Text] [Related]
24. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Shibata M; Kodani I; Osaki M; Araki K; Adachi H; Ryoke K; Ito H Oral Oncol; 2005 Mar; 41(3):304-12. PubMed ID: 15743693 [TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1. Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912 [TBL] [Abstract][Full Text] [Related]
26. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425 [TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation. Duan W; Zhang L Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538 [TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Atula T; Hedström J; Ristimäki A; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C Oncol Rep; 2006 Sep; 16(3):485-90. PubMed ID: 16865247 [TBL] [Abstract][Full Text] [Related]
31. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645 [TBL] [Abstract][Full Text] [Related]
32. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Liao Z; Milas L; Komaki R; Stevens C; Cox JD Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863 [TBL] [Abstract][Full Text] [Related]
33. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
34. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase. Kim SH; Kim SH; Song YC; Song YS Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114 [TBL] [Abstract][Full Text] [Related]
35. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
36. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. Chen PY; Long QC Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070 [TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
39. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386 [TBL] [Abstract][Full Text] [Related]
40. Expression of cytosolic phospholipase A2 and cyclooxygenase 2 and their significance in human oral mucosae, dysplasias and squamous cell carcinomas. Zhang S; Du Y; Tao J; Wu Y; Chen N ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):242-8. PubMed ID: 18467819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]